600276.SS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 geg. 2024 @ 10:00):

Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403 for oncology, metabolic, pain, autoimmune, and other indications...

Stats
Dzisiejszy wolumen	20.38M
Średni wolumen	28.54M
Kapitalizacja rynkowa	300.01B
EPS	CNY0.210 ( 2024-04-25 )
Następna data zysków	( CNY0.0297 ) 2024-05-15
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	67.47
ATR14	CNY0.0320 (0.07%)

Wolumen Korelacja

Długi: -0.17 (neutral)

Krótki: 0.49 (neutral)

Signal:(46.805) Neutral

Jiangsu Hengrui Medicine Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Jiangsu Hengrui Medicine Korelacja - Waluta/Towar

-0.66
( moderate negative )

-0.03
( neutral )

0.00
( neutral )

-0.80
( moderate negative )

-0.02
( neutral )

0.87
( strong )

Jiangsu Hengrui Medicine Finanse

Annual	2023
Przychody:	CNY22.82B
Zysk brutto:	CNY19.29B (84.55 %)
EPS:	CNY0.680

FY	2023
Przychody:	CNY22.82B
Zysk brutto:	CNY19.29B (84.55 %)
EPS:	CNY0.680

FY	2022
Przychody:	CNY21.28B
Zysk brutto:	CNY17.79B (83.61 %)
EPS:	CNY0.610

FY	2021
Przychody:	CNY25.91B
Zysk brutto:	CNY22.16B (85.56 %)
EPS:	CNY0.710

Financial Reports:

No articles found.

Jiangsu Hengrui Medicine